LAWRENCE, Mass., Sept. 10, 2015 /PRNewswire/ -- NxStage
Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of
dialysis products, today announced plans to showcase its latest
breakthrough technologies and discuss its financial results for the
third quarter ending September 30,
2015, at its financial analyst day on Tuesday, November 3, 2015 from 9:00 a.m. to approximately 12:00 p.m. ET at its headquarters in Lawrence, MA. During the event, NxStage
management will also unveil additional details of new innovations
from its robust pipeline including its next generation hemodialysis
system, its peritoneal dialysis (PD) system and next generation
critical care system. NxStage plans to release its third quarter
financial results before the opening of the financial markets on
November 3, 2015.
Conference Call and Webcast Information
NxStage
invites the public and media to view the presentation slides and
listen to the live audio webcast of the event through the Investor
Relations section of the Company's website at
http://ir.nxstage.com/. An audio replay of the webcast will be
available shortly after the end of the event at the same
location.
Event Registration
Members of the investment
community interested in attending NxStage's Financial Analyst Day
in Lawrence, MA are asked to
contact the Investor Relations department at ir@nxstage.com.
Registration is required to attend the event.
About NxStage Medical
NxStage Medical
Inc. (Nasdaq: NXTM) is a medical device company, headquartered
in Lawrence, Massachusetts,
USA, that develops, manufactures and markets innovative
products for the treatment of ESRD and acute kidney failure. For
more information on NxStage and its products, please visit the
Company's website at www.nxstage.com.
Forward-Looking Statements
This release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements contained
in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended
to identify forward-looking statements. Actual results may differ
materially from those indicated by these forward-looking statements
as a result of various important factors including those that are
discussed in NxStage's filings with the Securities and Exchange
Commission, including the Quarterly Report on Form 10-Q for the
quarter ended June 30, 2015. NxStage
is under no obligation to (and expressly disclaims any such
obligation to) update or alter its forward-looking statements,
whether as a result of new information, future events or
otherwise.
Media contact:
Kristen K. Sheppard, Esq.
ksheppard@nxstage.commailto:ksheppard@nxstage.com
Tel: (978) 332-5923
Logo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
Logo - http://photos.prnewswire.com/prnh/20150624/225341
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nxstage-to-showcase-latest-breakthrough-technologies-at-financial-analyst-day-schedules-third-quarter-2015-financial-results-300140490.html
SOURCE NxStage Medical, Inc.